Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Light Therapy in End Stage Kidney Disease

NCT: NCT06310161 · RECRUITING

NCT IDNCT06310161
StatusRECRUITING
Start Date2026-02-01
Completion2026-08-01

Brief Summary

The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis. The main aim is to determine if light therapy decreases fatigue severity. Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment.

Frequently Asked Questions

What is Light Therapy in End Stage Kidney Disease?

Light Therapy in End Stage Kidney Disease is a clinical trial registered under NCT06310161. Current status: RECRUITING.

What is the status of NCT06310161?

The current status of NCT06310161 (Light Therapy in End Stage Kidney Disease) is: RECRUITING.

When did Light Therapy in End Stage Kidney Disease start?

Light Therapy in End Stage Kidney Disease started on 2026-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.